Talking it out: study tests if doctor training eases cancer Survivors' transition
NCT ID NCT01483664
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether training doctors in communication skills can help lymphoma patients move from active treatment to survivorship. It involves 314 patients with Hodgkin's or Diffuse Large B-cell Lymphoma. The goal is to see if better conversations with their doctors improve patient outcomes during this challenging transition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- communication skills training
- What this could lead to
- If successful, this could show that better doctor-patient communication improves the emotional and practical well-being of lymphoma survivors.
- What could go wrong
- This is an early-stage behavioral study, not a drug trial. Results may not show a clear benefit, and the training may not be widely adopted.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Maimonides Medical Center
Brooklyn, New York, 11220, United States
-
Md Anderson Cancer Center
Houston, Texas, 77030, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Memorial Sloan Kettering Cancer Center at Commack
Commack, New York, 11725, United States
-
Memorial Sloan Kettering Cancer Center at Mercy
Rockville Centre, New York, 11570, United States
-
Memorial Sloan Kettering Cancer Center at Phelps
Sleepy Hollow, New York, 10591, United States
-
Memorial Sloan Kettering at Basking Ridge
Basking Ridge, New Jersey, 07920, United States
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
-
Tampa General Hospital
Tampa, Florida, 33606, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can immune cells plus a checkpoint drug outsmart lymphoma?
- Can an immune booster outsmart brain lymphoma?
- A shot at safer CAR t: early brain protection for lymphoma patients?
- Can donor immune cells be engineered to fight blood cancer?
- Can a simple blood test spot lymphoma earlier?
- Can a Light-Based device spot dangerous infection risk without a blood draw?